Public record of meeting, 9 June, 2014

Meeting of 9 June, 2014–10 June, 2014

PDF Version



  • Dr. Marcello Tonelli (Chair)
  • Dr. Richard Birtwhistle (Vice-Chair)
  • Dr. Maria Bacchus
  • Dr. Neil Bell
  • Dr. Paula Brauer
  • Dr. Jim Dickinson
  • Dr. Roland Grad
  • Dr. Gabriela Lewin
  • Dr. Patricia Parkin
  • Dr. Kevin Pottie
  • Dr. Harminder Singh
  • Dr. Brett Thombs


  • Dr. Karen Grimsrud
  • Dr. Sarah Connor Gorber
  • Dr. Lesley Dunfield
  • Ms. Alejandra Jaramillo


  • Ms. Donna Fitzpatrick-Lewis
  • Dr. Diana Sherifali

University of Alberta

  • Ms Brandee Borne
  • Ms Dawn Opgenorth

St. Michael’s Hospital

  • Mr. Marlon Rhoden


  • Ms. Diane Finkle Perazzo


  • Dr. Ainsley Moore
  • Dr. Parminder Raina
  • Dr. Sharon Straus


1. Welcome and Introductions

Dr. Lewin made a motion to approve the February 2014 CTFPHC Meeting Minutes and PROM. This motion was seconded by Dr. Birtwhistle and unanimously passed. CTFPHC members reviewed the list of Actions Items from February Meeting and the Agenda and expectations for the June 2014 meeting.


2. Guideline Timelines Overview

Dr. Connor Gorber reviewed a Forward Agenda which had been prepared to enhance the decision-making process at upcoming CTFPHC Meetings. The CTFPHC discussed a variety of issues and stressed the importance of an ongoing process to develop KT products that reflect provincial and national changes in practice.


3. Prevention Guideline Division Update

Dr. Grimsrud provided an update regarding the work of PHAC’s Prevention Guidelines Division. She covered staffing issues and the current selection and funding process for CTFPHC evidence review and synthesis. Dr. Grimsrud also reviewed events and decisions from a recent USPSTF Partners Meeting held in May 2014.


4. Colorectal Cancer Working Group Report

Dr. Bacchus and Ms. Fitzpatrick-Lewis presented the results of the literature review process for colorectal cancer screening and draft recommendations for colorectal cancer screening. CTFPHC members discussed a number of issues and provided feedback on the proposed recommendations.


5. Developmental Delay Working Group Report

Dr. Sherifali presented the results of the literature review process about screening for developmental delay. CTFPHC members provided input into this issue and discussed a number of key issues.


6. E-Health Update

Dr. Birtwhistle updated the CTFPHC regarding progress on the development of a mobile app and EMR Integration Tool. A contract has been awarded for the development of a mobile app and it is expected this product will be available in the near future. CTFPHC members also discussed the importance of integrating the mobile app with the EMR and stressed the importance of the EMR in current family practice.


7. ERSC Update

Ms. Fitzpatrick-Lewis and Dr. Sherifali provided a brief report regarding the work of the Evidence Review and Synthesis Centre.


8. SharePoint Update

Ms. Borne reported that the SharePoint system was moving forward and all staff and CTFPHC members should be set up as users in the near future. Webinar training will take place ASAP.


9. Topics Report

Dr. Dunfield reported on current rankings and the status of topics with other organizations. She stressed the need for a decision on future topics. CTFPHC members agreed that there was a need to capitalize on the scoping process to enhance decision-making on topics.


10. Task Force Membership

Dr. Tonelli reported that there were currently two membership vacancies on the CTFPHC and requested that members share this information among their colleagues.


11. Periodic Health Exam Working Group

Dr. Birtwhistle updated the CTFPHC regarding the development of CPGs on the periodic health exam. He noted that a position paper is being developed and that it will be important for the CTFPHC to clearly define whether this issue should be reframed as a preventive health visit and not an “examination”. CTFPHC members agreed that this was an important issue and would provide an opportunity to frame a variety of messages for the public.


12. Presentation of Adult Obesity CPGs

Dr. Paula Brauer presented draft recommendations for the prevention of adult obesity. CTFPHC members provided feedback on a variety of issues.


13. KT Working Group Report

Mr. Rhoden and Ms. Opgenorth provided an update on the recent activities of the KT Working Group including the development of the CTFPHC website, CME modules, the Breast Cancer Project, the CPHA Conference, the development of Prostate Cancer Tools and the updated media strategy. CTFPHC members provided input in a number of areas and recommended that the Breast Cancer Screening KT tools serve as models for the Prostate KT tools.


14. Cognitive Impairment Working Group Report

Dr. Pottie provided an update on the development of CPGs for the screening of cognitive impairment. CTFPHC members offered feedback in a variety of areas and provided provisional approval to distribute the CPG on screening for mild cognitive impairment for peer review.


15. Break Out Sessions

At the end of Day One, the Childhood Obesity and Cognitive Impairment Working Groups held brief meetings.


16. Child Obesity Working Group

Dr. Parkin reviewed the proposed prevention, treatment and screening recommendations for childhood obesity. CTFPHC members discussed a number of issues such as the need for a common system of measuring obesity in children and provided provisional approval to distribute the guidelines for peer review.


17. Visit to NICE – Learnings for CTFPHC

Dr. Grimsrud provided a detailed presentation regarding her visit to the National Institute of Health and Care Excellence (NICE) in England. She reviewed background on NICE, its public health guidance development process, public and stakeholder involvement and support, implementation tools, broader approach to the evidence and the “Top 3” lists.


18. Break Out Sessions

At the end of Day Two, the Adult Obesity and Colorectal Cancer Working Groups held brief meetings.


19. Cervical Cancer Update

Dr. Dunfield updated members on the progress of the cervical cancer screening literature surveillance, HPV co-testing and considerations for an updated CPG and/or a new CPG for HPV that would include data from co-testing studies.


20. Next Steps and Adjournment

Prior to adjournment, there was discussion about the need to continue the discussion on patient involvement and patient preferences. It was agreed that this issue would be taken to the Methods Working Group for discussion.


The next meeting will be held on October 27 – 28, 2014 in Ottawa.